 | • レポートコード：GIR201105767 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ニューロペプチドY受容体タイプ2の世界市場を調査対象にし、ニューロペプチドY受容体タイプ2の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（XL-310、NN-9748、GT-002、その他）、用途別分析（肥満、てんかん、2型糖尿病、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Gila Therapeutics Inc、Novo Nordisk A/S、XL-protein GmbH ・メーカー別販売量、売上、市場シェア ・ニューロペプチドY受容体タイプ2の地域別市場分析 ・ニューロペプチドY受容体タイプ2の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ニューロペプチドY受容体タイプ2のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ニューロペプチドY受容体タイプ2のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ニューロペプチドY受容体タイプ2の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ニューロペプチドY受容体タイプ2の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ニューロペプチドY受容体タイプ2の種類別市場規模2015-2020：XL-310、NN-9748、GT-002、その他 ・ニューロペプチドY受容体タイプ2の用途別市場規模2015-2020：肥満、てんかん、2型糖尿病、その他 ・ニューロペプチドY受容体タイプ2の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Neuropeptide Y Receptor Type 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neuropeptide Y Receptor Type 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neuropeptide Y Receptor Type 2 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuropeptide Y Receptor Type 2 market has been segmented into
XL-310
NN-9748
GT-002
Others
By Application, Neuropeptide Y Receptor Type 2 has been segmented into:
Obesity
Epilepsy
Type 2 Diabetes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuropeptide Y Receptor Type 2 market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuropeptide Y Receptor Type 2 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuropeptide Y Receptor Type 2 market.
The report offers in-depth assessment of the growth and other aspects of the Neuropeptide Y Receptor Type 2 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuropeptide Y Receptor Type 2 Market Share Analysis
Neuropeptide Y Receptor Type 2 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuropeptide Y Receptor Type 2 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuropeptide Y Receptor Type 2 sales, revenue and market share for each player covered in this report.
The major players covered in Neuropeptide Y Receptor Type 2 are:
Gila Therapeutics Inc
Novo Nordisk A/S
XL-protein GmbH
Among other players domestic and global, Neuropeptide Y Receptor Type 2 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuropeptide Y Receptor Type 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuropeptide Y Receptor Type 2, with price, sales, revenue and global market share of Neuropeptide Y Receptor Type 2 in 2018 and 2019.
Chapter 3, the Neuropeptide Y Receptor Type 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuropeptide Y Receptor Type 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuropeptide Y Receptor Type 2 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuropeptide Y Receptor Type 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neuropeptide Y Receptor Type 2 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuropeptide Y Receptor Type 2 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 XL-310
1.2.3 NN-9748
1.2.4 GT-002
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuropeptide Y Receptor Type 2 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Obesity
1.3.3 Epilepsy
1.3.4 Type 2 Diabetes
1.3.5 Others
1.4 Overview of Global Neuropeptide Y Receptor Type 2 Market
1.4.1 Global Neuropeptide Y Receptor Type 2 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gila Therapeutics Inc
2.1.1 Gila Therapeutics Inc Details
2.1.2 Gila Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gila Therapeutics Inc SWOT Analysis
2.1.4 Gila Therapeutics Inc Product and Services
2.1.5 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novo Nordisk A/S SWOT Analysis
2.2.4 Novo Nordisk A/S Product and Services
2.2.5 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 XL-protein GmbH
2.3.1 XL-protein GmbH Details
2.3.2 XL-protein GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 XL-protein GmbH SWOT Analysis
2.3.4 XL-protein GmbH Product and Services
2.3.5 XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuropeptide Y Receptor Type 2 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuropeptide Y Receptor Type 2 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuropeptide Y Receptor Type 2 Manufacturer Market Share in 2019
3.3.2 Top 6 Neuropeptide Y Receptor Type 2 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuropeptide Y Receptor Type 2 Sales, Revenue and Market Share by Regions
4.1.1 Global Neuropeptide Y Receptor Type 2 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuropeptide Y Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
4.3 Europe Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
4.5 South America Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuropeptide Y Receptor Type 2 Sales, Revenue and Market Share by Country
5.1.1 North America Neuropeptide Y Receptor Type 2 Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuropeptide Y Receptor Type 2 Revenue and Market Share by Country (2015-2020)
5.2 United States Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
5.3 Canada Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
5.4 Mexico Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuropeptide Y Receptor Type 2 Sales, Revenue and Market Share by Country
6.1.1 Europe Neuropeptide Y Receptor Type 2 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuropeptide Y Receptor Type 2 Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
6.3 UK Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
6.4 France Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
6.5 Russia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
6.6 Italy Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuropeptide Y Receptor Type 2 Revenue and Market Share by Regions (2015-2020)
7.2 China Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
7.3 Japan Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
7.4 Korea Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
7.5 India Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
7.7 Australia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuropeptide Y Receptor Type 2 Sales, Revenue and Market Share by Country
8.1.1 South America Neuropeptide Y Receptor Type 2 Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuropeptide Y Receptor Type 2 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
8.3 Argentina Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuropeptide Y Receptor Type 2 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuropeptide Y Receptor Type 2 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuropeptide Y Receptor Type 2 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
9.3 Turkey Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
9.4 Egypt Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
9.5 South Africa Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuropeptide Y Receptor Type 2 Sales and Market Share by Type (2015-2020)
10.2 Global Neuropeptide Y Receptor Type 2 Revenue and Market Share by Type (2015-2020)
10.3 Global Neuropeptide Y Receptor Type 2 Price by Type (2015-2020)
11 Global Neuropeptide Y Receptor Type 2 Market Segment by Application
11.1 Global Neuropeptide Y Receptor Type 2 Sales Market Share by Application (2015-2020)
11.2 Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Application (2015-2020)
11.3 Global Neuropeptide Y Receptor Type 2 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuropeptide Y Receptor Type 2 Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuropeptide Y Receptor Type 2 Market Forecast by Regions (2021-2025)
12.2.1 North America Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025)
12.2.2 Europe Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025)
12.2.4 South America Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025)
12.3 Neuropeptide Y Receptor Type 2 Market Forecast by Type (2021-2025)
12.3.1 Global Neuropeptide Y Receptor Type 2 Sales Forecast by Type (2021-2025)
12.3.2 Global Neuropeptide Y Receptor Type 2 Market Share Forecast by Type (2021-2025)
12.4 Neuropeptide Y Receptor Type 2 Market Forecast by Application (2021-2025)
12.4.1 Global Neuropeptide Y Receptor Type 2 Sales Forecast by Application (2021-2025)
12.4.2 Global Neuropeptide Y Receptor Type 2 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neuropeptide Y Receptor Type 2 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuropeptide Y Receptor Type 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuropeptide Y Receptor Type 2 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Gila Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Major Business
Table 9. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 10. Gila Therapeutics Inc SWOT Analysis
Table 11. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Product and Services
Table 12. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 14. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Major Business
Table 15. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 16. Novo Nordisk A/S SWOT Analysis
Table 17. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Product and Services
Table 18. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. XL-protein GmbH Basic Information, Manufacturing Base and Competitors
Table 20. XL-protein GmbH Neuropeptide Y Receptor Type 2 Major Business
Table 21. XL-protein GmbH Neuropeptide Y Receptor Type 2 Total Revenue (USD Million) (2018-2019)
Table 22. XL-protein GmbH SWOT Analysis
Table 23. XL-protein GmbH Neuropeptide Y Receptor Type 2 Product and Services
Table 24. XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Neuropeptide Y Receptor Type 2 Sales by Manufacturer (2018-2019) (K Pcs)
Table 26. Global Neuropeptide Y Receptor Type 2 Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Neuropeptide Y Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 28. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 29. Global Neuropeptide Y Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Neuropeptide Y Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 31. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 32. North America Neuropeptide Y Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 34. Europe Neuropeptide Y Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 35. Europe Neuropeptide Y Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 36. Europe Neuropeptide Y Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Regions (2015-2020) (K Pcs)
Table 38. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Neuropeptide Y Receptor Type 2 Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Neuropeptide Y Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 41. South America Neuropeptide Y Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 42. South America Neuropeptide Y Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Neuropeptide Y Receptor Type 2 Sales by Countries (2015-2020) (K Pcs)
Table 45. Middle East & Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Neuropeptide Y Receptor Type 2 Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Table 48. Global Neuropeptide Y Receptor Type 2 Sales by Type (2015-2020) (K Pcs)
Table 49. Global Neuropeptide Y Receptor Type 2 Sales Share by Type (2015-2020)
Table 50. Global Neuropeptide Y Receptor Type 2 Revenue by Type (2015-2020) (USD Million)
Table 51. Global Neuropeptide Y Receptor Type 2 Revenue Share by Type (2015-2020)
Table 52. Global Neuropeptide Y Receptor Type 2 Sales by Application (2015-2020) (K Pcs)
Table 53. Global Neuropeptide Y Receptor Type 2 Sales Share by Application (2015-2020)
Table 54. Global Neuropeptide Y Receptor Type 2 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 55. Global Neuropeptide Y Receptor Type 2 Market Share Forecast by Regions (2021-2025)
Table 56. Global Neuropeptide Y Receptor Type 2 Sales Forecast by Type (2021-2025) (K Pcs)
Table 57. Global Neuropeptide Y Receptor Type 2 Market Share Forecast by Type (2021-2025)
Table 58. Global Neuropeptide Y Receptor Type 2 Sales Forecast by Application (2021-2025)
Table 59. Global Neuropeptide Y Receptor Type 2 Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neuropeptide Y Receptor Type 2 Picture
Figure 2. Global Sales Market Share of Neuropeptide Y Receptor Type 2 by Type in 2019
Figure 3. XL-310 Picture
Figure 4. NN-9748 Picture
Figure 5. GT-002 Picture
Figure 6. Others Picture
Figure 7. Neuropeptide Y Receptor Type 2 Sales Market Share by Application in 2018
Figure 8. Obesity Picture
Figure 9. Epilepsy Picture
Figure 10. Type 2 Diabetes Picture
Figure 11. Others Picture
Figure 12. Global Neuropeptide Y Receptor Type 2 Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Neuropeptide Y Receptor Type 2 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Neuropeptide Y Receptor Type 2 Sales Market Share by Manufacturer in 2019
Figure 33. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Neuropeptide Y Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Neuropeptide Y Receptor Type 2 Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Regions (2015-2020)
Figure 40. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Regions in 2018
Figure 41. North America Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 42. Europe Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 44. South America Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020)
Figure 46. North America Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Countries (2015-2020)
Figure 48. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Countries in 2018
Figure 49. North America Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries in 2018
Figure 51. United States Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 57. Germany Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Neuropeptide Y Receptor Type 2 Revenue Market Share by Regions 2019
Figure 65. China Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Neuropeptide Y Receptor Type 2 Sales Market Share by Countries in 2019
Figure 72. South America Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 73. Brazil Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Neuropeptide Y Receptor Type 2 Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Neuropeptide Y Receptor Type 2 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Neuropeptide Y Receptor Type 2 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Neuropeptide Y Receptor Type 2 Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
グルカゴン様ペプチド2受容体の世界市場 2020年 Market Overview The global Glucagon Like Peptide 2 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glucagon Lik…- N-ホルミルペプチド受容体2の世界市場 2020年 Market Overview The global N-Formyl Peptide Receptor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The N-Formyl Peptide …
- アリール炭化水素受容体の世界市場 2020年 Market Overview The global Aryl Hydrocarbon Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Aryl Hydrocarbon Re…
- ソマトスタチン受容体4型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…
- メラニン濃縮ホルモン受容体1の世界市場 2020年 Market Overview The global Melanin Concentrating Hormone Receptor 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mela…